AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 141 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,610,000 | +791.5% | 160,578 | +318.3% | 0.01% | +400.0% |
| Q3 2019 | $1,078,000 | -9.6% | 38,386 | +21.8% | 0.00% | 0.0% |
| Q2 2019 | $1,193,000 | +24.9% | 31,525 | +28.7% | 0.00% | 0.0% |
| Q1 2019 | $955,000 | +274.5% | 24,487 | +104.7% | 0.00% | – |
| Q4 2018 | $255,000 | -67.6% | 11,964 | -39.9% | 0.00% | -100.0% |
| Q3 2018 | $788,000 | +323.7% | 19,896 | +309.6% | 0.00% | – |
| Q2 2018 | $186,000 | -51.9% | 4,857 | -62.3% | 0.00% | – |
| Q1 2018 | $387,000 | +294.9% | 12,898 | +311.4% | 0.00% | – |
| Q4 2017 | $98,000 | -14.0% | 3,135 | -23.2% | 0.00% | – |
| Q3 2017 | $114,000 | +660.0% | 4,084 | +436.0% | 0.00% | – |
| Q2 2017 | $15,000 | -83.5% | 762 | -85.8% | 0.00% | – |
| Q1 2017 | $91,000 | +295.7% | 5,374 | +299.9% | 0.00% | – |
| Q4 2016 | $23,000 | – | 1,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |